Qianjiang Yongan Pharmaceutical Co., Ltd. (SHE:002365)
China flag China · Delayed Price · Currency is CNY
12.24
-0.33 (-2.63%)
May 21, 2026, 3:04 PM CST

SHE:002365 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
253.21230.59320.41326.17274.7293.51
Trading Asset Securities
622.77687.89600.16630.1557.5454.02
Cash & Short-Term Investments
875.98918.47920.57956.27832.22547.53
Cash Growth
-2.92%-0.23%-3.73%14.91%52.00%-26.83%
Accounts Receivable
162.85124.97161.79171.53187.23332.27
Other Receivables
3.115.446.146.338.1211.63
Receivables
165.96130.41167.93177.86195.35343.9
Inventory
78.9790.8993.569.9149.6145.78
Other Current Assets
18.212.9716.669.5718.1828.69
Total Current Assets
1,1391,1531,1991,2141,1951,066
Property, Plant & Equipment
889.27878.49948.07953.611,022988.96
Long-Term Investments
75.374.4674.5568.381.37115.23
Goodwill
---0.528.778.77
Other Intangible Assets
75.9676.8279.5682.3984.4987.93
Long-Term Deferred Tax Assets
11.8611.415.8411.269.739.94
Other Long-Term Assets
3.726.741.9317.4622.039.21
Total Assets
2,1952,2012,3092,3472,4242,286
Accounts Payable
113.5115.57124.02160.65162.77114.91
Accrued Expenses
26.1639.641.0740.0447.547
Short-Term Debt
0.750.7539.5310.0140.0120.38
Current Income Taxes Payable
12.648.917.067.840.612.37
Current Unearned Revenue
25.1620.119.2815.5911.7721.53
Other Current Liabilities
13.1519.0117.3823.1222.4687.18
Total Current Liabilities
191.36203.94248.34257.26285.13293.37
Long-Term Unearned Revenue
8.89.287.468.511.3113.05
Long-Term Deferred Tax Liabilities
4.355.510.7533.0924.7422.53
Total Liabilities
204.51218.72266.55298.85321.17328.95
Common Stock
294.68294.68294.68294.68294.68294.68
Additional Paid-In Capital
722.3722.3714.44712.92712.78712.23
Retained Earnings
987.22979.48985.91953.42995.2854.85
Treasury Stock
-40.48-40.48-24.18---
Comprehensive Income & Other
31.831.0222.9422.8914.714.16
Total Common Equity
1,9961,9871,9941,9842,0171,866
Minority Interest
-4.82-5.0748.2864.3885.6391.06
Shareholders' Equity
1,9911,9822,0422,0482,1031,957
Total Liabilities & Equity
2,1952,2012,3092,3472,4242,286
Total Debt
0.750.7539.5310.0140.0120.38
Net Cash (Debt)
875.24917.72881.04946.26792.2527.15
Net Cash Growth
0.28%4.16%-6.89%19.45%50.28%-15.78%
Net Cash Per Share
3.033.172.993.212.691.84
Filing Date Shares Outstanding
288.68289.15289.15294.68294.68294.68
Total Common Shares Outstanding
288.68289.15291.24294.68294.68294.68
Working Capital
947.76948.81950.32956.34910.22772.52
Book Value Per Share
6.916.876.856.736.856.33
Tangible Book Value
1,9201,9101,9141,9011,9241,769
Tangible Book Value Per Share
6.656.616.576.456.536.00
Buildings
-633.95581.93573.53546.87547.89
Machinery
-1,3351,3061,2681,2101,083
Construction In Progress
-18.966.4126.1251.5543.07
Source: S&P Global Market Intelligence. Standard template. Financial Sources.